Argumentaire d'investissement pour l'hépatite B et C en Afrique du Sud: adaptation et innovation dans l'analyse des politiques pour l'intensification des programmes de lutte contre la maladie
Summary Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have […]